TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway

被引：0
|
作者：
Ying Xing
Yuechao Liu
Tianbo Liu
Qingwei Meng
Hailing Lu
Wei Liu
Jing Hu
Chunhong Li
Mengru Cao
Shi Yan
Jian Huang
Ting Wang
Li Cai
机构：
[1] Harbin Medical University Cancer Hospital,The Fourth Department of Medical Oncology
[2] Harbin Medical University Cancer Hospital,Department of Gynecology
[3] Harbin Medical University,The Sixth Department of Medical Oncology
[4] Harbin Medical University Cancer Hospital,undefined
来源：
Cell Communication and Signaling | / 16卷
关键词：
TNFAIP8; NSCLC; Proliferation; Cisplatin chemoresistance; MDM2/p53 pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] p53 gene status and modulation of response to cisplatin chemotherapy in non-small cell lung cancer cells
    Barr, M. P.
    Batina, M. B.
    Cuffe, S.
    Finn, S.
    O'Byrne, K. J.
    LUNG CANCER, 2014, 83 : S1 - S1
  • [42] Germacrone induces lung cancer cell apoptosis and cell cycle arrest via the Akt/MDM2/p53 signaling pathway
    Zhao, Yang
    Cai, Jie
    Shi, Kaihu
    Li, Hang
    Du, Jin
    Hu, Dinghui
    Liu, Zuntao
    Wang, Wei
    MOLECULAR MEDICINE REPORTS, 2021, 23 (06)
  • [43] TDIF1 promotes non-small cell lung cancer development through P53/HDAC1/2 axis
    Wang, Z.
    Zhang, Y.
    Huang, Y.
    Liu, Q.
    Cao, F.
    Zhang, M.
    Liu, Y.
    Wang, Y.
    Ying, M.
    Yuan, K.
    Min, W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 311 - 311
  • [44] Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: An alternative pathway to non-small-cell lung cancer
    Wang, YC
    Lin, RK
    Tan, YH
    Chen, JT
    Chen, CY
    Wang, YC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 154 - 164
  • [45] The expression of GST isoenzymes and p53 in non-small cell lung cancer
    Oguztuzun, Serpil
    Aydin, Mehtap
    Demirag, Funda
    Yazici, Ulku
    Ozhavzali, Muzeyyen
    Kilic, Murat
    Iscan, Mesude
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2010, 48 (01) : 122 - 127
  • [46] Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non-Small Cell Lung Cancer Cells
    Day, Timothy F.
    Kallakury, Bhaskar V. S.
    Ross, Jeffrey S.
    Voronel, Olga
    Vaidya, Shantashri
    Sheehan, Christine E.
    Kasid, Usha N.
    MOLECULAR CANCER RESEARCH, 2019, 17 (05) : 1207 - 1219
  • [47] Clinical significance of p53 in non-small cell lung cancer (Review)
    Komiya, T
    Hirashima, T
    Kawase, I
    ONCOLOGY REPORTS, 1999, 6 (01) : 19 - 28
  • [48] Lipopolysaccharide Affects the Proliferation and Glucose Metabolism of Cervical Cancer Cells Through the FRA1/MDM2/p53 Pathway
    Jiang, Xiaoyan
    Yuan, Jing
    Dou, Yingyu
    Zeng, Da
    Xiao, Songshu
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (04): : 1030 - 1038
  • [49] Anlotinib induced ferroptosis through the p53/xCT/GPX4 pathway in non-small cell lung cancer
    Jiang, Zhansheng
    Sun, Xinge
    Li, Yuan
    Wang, Jiahe
    Wang, Cong
    Pan, Zhanyu
    Yang, Yinli
    TRANSLATIONAL ONCOLOGY, 2025, 53
  • [50] MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation
    D-L Qi
    D Cobrinik
    Oncogene, 2017, 36 : 1760 - 1769
12345